Gilead Sciences sees strong growth in HIV & oncology with BIKTARVY & TRODELVY. Learn about upcoming drugs & market potential ...
In the closing of the recent trading day, Gilead Sciences (GILD) stood at $105.87, denoting a -1.53% change from the preceding trading day.
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $90 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback